Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis

Journal of Oral Pathology and Medicine

Volumn 39, Issue 1, 2010, Pages 74-78

  Ohba, Shinichi ^a,b   Fujii, Hiroaki ^b   Ito, Shin ^b   Fujimaki, Mitsuhisa ^b   Matsumoto, Fumihiko ^b   Furukawa, Masayuki ^b   Yokoyama, Junkichi ^b   Kusunoki, Takeshi ^b   Ikeda, Katsuhisa ^b   Hino, Okio ^b  

^a School of Medicine ^*  (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Glucose transporter 1 (GLUT 1); Invasion front; Oral squamous cell carcinoma; Overexpression

Indexed keywords

GLUCOSE TRANSPORTER 1; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; CYTOPLASM; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 76249085615     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00814.x     Document Type: Article

References (22)

1. Kato Y, Tsuta K, Seki K, et al. Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol 2007 20 : 215 220.
2. Harber RS, Rathan A, Weiser K, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 1998 83 : 34 40.
3. Younes M, Brown R, Stephenson M, Gondo M, Cagle P. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 1997 80 : 1046 1051.
4. Kang SS, Chun YK, Hur MH, et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 2002 93 : 1123 1128.
5. Tohma T, Okazumi S, Makino H, et al. Overexpression of glucose transporter 1 in esophageal squamous cell carcinomas: a marker for poor prognosis. Dis Esophagus 2005 18 : 185 189.
6. Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 2001 92 : 634 641.
7. Rudlowski C, Moser M, Becker A, et al. GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Oncology 2004 66 : 404 410.
8. Kim YW, Park YK, Yoon TY, Lee SM. Expression of the GLUT1 glucose transporter in gallbladder carcinomas. Hepatogastroenterology 2002 49 : 907 911.
9. Kunkel M, Reichert TE, Benz P, et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003 97 : 1015 1024.
10. Mori Y, Tsukinoki K, Yasuda M, Miyazawa M, Kaneko A, Watanabe Y. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors. Oral Oncol 2007 43 : 563 569.
11. Mineta H, Miura K, Takebayashi S, et al. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma. Anticancer Res 2002 22 : 3489 3494.
12. Okamoto M, Nishimine M, Kishi M, et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 2002 31 : 227 233.
13. Marcin N, Januszz AM. Expression of E-cadherin, β-catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinoma in bitches. Folia Histochem Cytobiol 2007 45 : 233 238.
14. Harada H, Kobayashi K, Maeda A. Predictive indicators for occult lymph node metastasis in N0 cases of squamous tongue carcinoma. J Oral Tumor 2001 13 : 313 317.
15. Reisser C, Eichhorn K, Herold-Mende C, Born A, Bannash P. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer 1999 80 : 194 198. (Pubitemid 29001721)
16. Airley RE, Loncaster J, Raleigh J, et al. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 2003 104 : 85 91.
17. Hutchison GJ, Valentine HR, Loncaster JA, et al. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin Cancer Res 2004 10 : 8405 8412.
18. Tanaka N, Kato H, Inose T, et al. Expression of carbonic anhydrase 9, a potential intrinsic marker of hypoxia, is associated with poor prognosis in oesophageal squamous cell carcinoma. Br J Cancer 2008 99 : 1468 1475.
19. Airley R, Loncaster J, Davidson S, et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001 7 : 928 934.
20. Grobholz R, Hacker HJ, Threns B, Bannsch P. Reduction in the expression of glucose transporter protein GLUT2 in preneoplastic and neoplastic hepatic lesions and reexpression of GLUT-1 in late stages of hepatocarcinogenesis. Cancer Res 1993 53 : 4204 4211.
21. Kato H, Takita J, Miyazaki T, et al. Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness. Anticancer Res 2002 22 : 2635 2639.
22. Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997 38 : 1907 1911.